$Pfizer (PFE.US)$ If the stock can stay above 27, the uptrend is more likely to be sustainable. Go Go Go
1
1
Report
Demon Town
:
I like you, but once again, the whole “trend or resistance” concept is an illusion. History shouldn’t be used to predict the future—only as a guideline.
$Johnson & Johnson (JNJ.US)$ Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients
What happened: In recent weeks,$Janux Therapeutics (JANX.US)$has seen significant insider buying, notably from RA Capital Management, which acquired shares worth approximately $25.3M. Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges. Key Developments: 📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...
i think this is rising wedge andI think jt will go down. i already bought PUT.
If the stock can stay above 27, the uptrend is more likely to be sustainable. Go Go Go
Flight to safety to PFE once again when tech stocks sell off
maybe even blue pill check $Pfizer (PFE.US)$
Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients
Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges.
Key Developments:
📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...
No comment yet